Painless Drug Delivery Through Microneedle-Based Transdermal Patches Featuring Active Infusion

This paper presents the first microneedle-based transdermal patch with integrated active dispensing functionality. The electrically controlled system consists of a low-cost dosing and actuation unit capable of controlled release of liquid in the microliter range at low flow-rates and minimally invasive, side-opened, microneedles. The system was successfully tested in vivo by insulin administration to diabetic rats. Active infusion of insulin at 2 mul/h was compared to passive, diffusion-driven, delivery. Continuous active infusion caused significantly higher insulin concentrations in blood plasma. After a 3-h delivery period, the insulin concentration was five times larger compared to passive delivery. Consistent with insulin concentrations, actively administered insulin resulted in a significant decrease of blood glucose levels. Additionally, insertion and liquid injection was verified on human skin. This study shows the feasibility of a patch-like system with on-board liquid storage and dispensing capability. The proposed device represents a first step towards painless and convenient administration of macromolecular drugs such as insulin or vaccines.

[1]  G. Kotzar,et al.  Evaluation of MEMS materials of construction for implantable medical devices. , 2002, Biomaterials.

[2]  Rebecca S. Shawgo,et al.  Biocompatibility and biofouling of MEMS drug delivery devices. , 2003, Biomaterials.

[3]  Mark R Prausnitz,et al.  Precise microinjection into skin using hollow microneedles. , 2006, The Journal of investigative dermatology.

[4]  J. Matriano,et al.  Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization , 2004, Pharmaceutical Research.

[5]  G. Stemme,et al.  A Thermally Responsive PDMS Composite and Its Microfluidic Applications , 2007, Journal of Microelectromechanical Systems.

[6]  B. W. Barry,et al.  Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  Eun Sok Kim,et al.  Film transfer and bonding technique to cover lab on a chip , 2005, The 13th International Conference on Solid-State Sensors, Actuators and Microsystems, 2005. Digest of Technical Papers. TRANSDUCERS '05..

[8]  Frantisek Svec,et al.  Flow control valves for analytical microfluidic chips without mechanical parts based on thermally responsive monolithic polymers. , 2003, Analytical chemistry.

[9]  Myron M. Levine,et al.  Can needle-free administration of vaccines become the norm in global immunization? , 2003, Nature Medicine.

[10]  M. Allen,et al.  Lack of Pain Associated with Microfabricated Microneedles , 2001, Anesthesia and analgesia.

[11]  Juan G. Santiago,et al.  A review of micropumps , 2004 .

[12]  S. Mitragotri,et al.  Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.

[13]  Shuvo Roy,et al.  An in vivo Biocompatibility Assessment of MEMS Materials for Spinal Fusion Monitoring , 2003 .

[14]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[15]  Wijaya Martanto,et al.  Mechanism of fluid infusion during microneedle insertion and retraction. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Diane E. Sutter,et al.  Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.

[17]  Göran Stemme,et al.  Side-opened out-of-plane microneedles for microfluidic transdermal liquid transfer , 2003 .

[18]  K M Halprin,et al.  EPIDERMAL “TURNOVER TIME”—A RE‐EXAMINATION , 1972, The British journal of dermatology.

[19]  Wijaya Martanto,et al.  Microinfusion Using Hollow Microneedles , 2006, Pharmaceutical Research.

[20]  Carlos H. Mastrangelo,et al.  Electrothermally actuated inline microfluidic valve , 2003 .

[21]  S. Plotkin,et al.  Vaccines: past, present and future , 2005, Nature Medicine.

[22]  Dorian Liepmann,et al.  Clinical microneedle injection of methyl nicotinate: stratum corneum penetration , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[23]  Wijaya Martanto,et al.  Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.

[24]  G. Holzapfel,et al.  Penetration-Enhanced Ultrasharp Microneedles and Prediction on Skin Interaction for Efficient Transdermal Drug Delivery , 2007, Journal of Microelectromechanical Systems.

[25]  Mark G. Allen,et al.  Hollow metal microneedles for insulin delivery to diabetic rats , 2005, IEEE Transactions on Biomedical Engineering.

[26]  Göran Stemme,et al.  Characterization of micromachined spiked biopotential electrodes , 2002, IEEE Transactions on Biomedical Engineering.

[27]  Regina Luttge,et al.  Silicon micromachined hollow microneedles for transdermal liquid transport , 2003 .

[28]  Mark R Prausnitz,et al.  Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.

[29]  K. Alberti,et al.  World book of diabetes in practice , 1986 .

[30]  Paul Geladi,et al.  Non‐invasive and microinvasive electrical impedance spectra of skin cancer – a comparison between two techniques , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[31]  Mark G. Allen,et al.  Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Cormier,et al.  Transdermal Delivery of Antisense Oligonucleotides with Microprojection Patch (macroflux®) Technology , 2001, Pharmaceutical Research.